Acción Cambio Fecha
ALKERMES USD 261.1M 37.86M 2026-09
Alnylam Pharmaceuticals USD 105.91M 8.8M 2026-09
Amarin USD 158.85M 5.22M 2026-09
ANI Pharmaceuticals USD 136.41M 6.74M 2026-09
Anika Therapeutics USD 28.56M 5.73M 2026-06
Arrowhead Research USD -173.08M 173.08M 2024-12
Eisai JPY 272.61B 15.06B 2026-09
Emergent BioSolutions USD 328.9M 25.2M 2023-12
GlaxoSmithKline GBP 6.28B 125M 2026-06
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 163.95M 21.56M 2026-09
Ligand Pharmaceuticals USD 14.51M 4.24M 2026-09
Merck USD 6.16B 43M 2026-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 66.1M 38.1M 2026-09
Omeros USD 712K 266K 2021-09
Pacira USD 3.83B 3.69B 2026-09
Regeneron Pharmaceuticals USD 2.89B 189.7M 2026-09
Roche Holding CHF 7.6B 9M 2025-06
Ultragenyx Pharmaceutical USD 59M 0 2026-09
Veracyte USD 25.82M 3.16M 2026-09
Vertex Pharmaceuticals USD 2.25B 480.2M 2026-09